Research graph
References from Recurrent Dedifferentiated Clival Chondrosarcoma Presenting 32 Years after Initial Treatment: A Case Report. Local targets link to admitted publications; unresolved targets remain external evidence.
Chondrosarcoma: a clinical review
10.3390/jcm12072506 · 2023 · External reference
Novel therapeutic approaches in chondrosarcoma
10.2217/fon-2016-0226 · 2017 · External reference
Skull base chondrosarcoma
10.1016/j.jocn.2015.10.029 · 2016 · External reference
Skull-base chondrosarcoma: a systematic review of the role of postoperative radiotherapy
10.3390/cancers16050856 · 2024 · External reference
Classification of chondrosarcoma: from characteristic to challenging imaging findings
10.3390/cancers15061703 · 2023 · External reference
Prognostic importance of IDH mutations in chondrosarcoma: an individual patient data meta-analysis
10.1002/cam4.4019 · 2021 · External reference
Multimodality treatment of skull base chondrosarcomas: the role of histology specific treatment protocols
10.1093/neuros/nyx042 · 2017 · External reference
Impact of adjuvant radiation therapy on outcomes in grade 2 conventional chondrosarcoma
10.3171/2025.3.jns242797 · 2025 · External reference
Chordoma and chondrosarcoma: similar, but quite different, skull base tumors
10.1002/cncr.23073 · 2007 · External reference
Chordoma: genetics and contemporary management
10.3390/ijms25115877 · 2024 · External reference
Chordomas: histopathological study in view of anatomical location
10.3346/jkms.2019.34.e107 · 2019 · External reference
Chordoma and chondrosarcoma
10.1016/j.otc.2015.02.009 · 2015 · External reference
Brachyury: a diagnostic marker for the differential diagnosis of chordoma and hemangioblastoma versus neoplastic histological mimickers
10.1155/2014/514753 · 2014 · External reference
Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas
10.1002/path.1969 · 2006 · External reference
Targeted next-generation sequencing of dedifferentiated chondrosarcoma in the skull base reveals combined TP53 and PTEN mutations with increased proliferation index, an implication for pathogenesis
10.18632/oncotarget.9618 · 2016 · External reference
Dedifferentiated chondrosarcoma from molecular pathology to current treatment and clinical trials
10.3390/cancers15153924 · 2023 · External reference
Dedifferentiated chondrosarcoma: prognostic factors and outcome from a European group
10.1016/j.ejca.2007.06.016 · 2007 · External reference
Chondrosarcoma resistance to radiation therapy: origins and potential therapeutic solutions
10.3390/cancers15071962 · 2023 · External reference
Radiation-induced intraspinal chondrosarcoma: a case report
10.1055/s-0035-1546953 · 2015 · External reference
Radiation-induced dedifferentiated chondrosarcoma with orbital invasion
10.1097/iop.0000000000000168 · 2014 · External reference
Management of recurrent or progressing skull base chondrosarcomas: predictors of long-term outcomes
10.1055/s-0040-1701523 · 2021 · External reference
Dedifferentiated Central Chondrosarcoma: A Clinical, Histopathological, and Immunohistochemical Analysis of 57 Cases
10.3389/fmed.2021.746909 · 2021 · External reference
IDH mutations in chondrosarcoma: case closed or not?
10.3390/cancers15143603 · 2023 · External reference
